6
Tetrahedron
ACCEPTED MANUSCRIPT
5.54; N, 18.11. Found: C, 65.95; H, 5.50; N, 18.18. HRMS-ESI
6H, H ), 2.34-2.30 (m, 4H, H ), 1.74-1.66 (m, 4H, H ); syn/anti
f
b
a
(m/z) calcd. for C34H35N8O4 [M + H]+ 619.2776, found 619.2781.
4.2.3. N'1 ,N'6 -bis((E)-5-((E)-(4-ethylphenyl)
diazenyl)-2-hydroxybenzylidene)adipohydrazide
(1c)
and/or anti/syn isomers, 47.2%: 11.77 (s, 1H, Hc (syn) or He (syn)),
11.57 (br, 1H, Hc (syn) or He (syn)), 11.39 (m, 1H, Hc (anti) or He (anti)),
10.36 (br, 1H, Hc (anti) or He (anti)), 8.49 (s, 1H, Hd (syn)), 8.41 (s, 1H,
Hd (anti)), 7.98 (d, J = 2.4 Hz, 1H, Hh (anti)), 7.90-7.79 (m, 5H, Hh
(syn), Hi), 7.62-7.50 (m, 7H, Hg (syn), Hk, Hl), 7.48 (d, J = 2 Hz, 1H,
Hg (anti)), 3.96-3.91 (m, 6H, Hf), 2.77-2.70 (m, 2H, Hb (anti)), 2.34-
2.30 (m, 2H, Hb (syn)), 1.74-1.66 (m, 4H, Ha); anti/anti isomer,
13.3%: 11.38 (m, 2H, Hc), 10.36 (br, 2H, He), 8.39 (s, 2H, Hd),
7.96 (d, J = 2 Hz, 2H, Hh), 7.90-7.79 (m, 4H, Hi), 7.62-7.50 (m,
6H, Hk, Hl), 7.43 (d, J = 2.4 Hz, 2H, Hg), 3.96-3.91 (m, 6H, Hf),
2.77-2.70 (m, 4H, Hb), 1.74-1.66 (m, 4H, Ha). 13C NMR (100
MHz, DMSO-d6, ppm): 174.51, 174.41, 169.01, 168.96, 152.44,
152.34, 150.75, 149.77, 149.27, 145.31, 145.22, 145.11, 139.66,
139.55, 131.32, 129.90, 129.76, 122.77, 121.06, 119.54, 119.39,
118.07, 104.43, 102.70, 56.47, 56.41, 34.44, 34.31, 32.32, 32.11,
25.19, 25.11, 24.51, 24.30. Anal. Calcd. For C34H34N8O6 (%): C,
62.67; H, 5.26; N, 17.25. Found: C, 62.58; H, 5.18; N, 17.33.
HRMS-ESI (m/z) calcd. for C34H35N8O6 [M + H]+ 651.2674,
found 651.2679.
Yield: 83%, mp 297-298 °C; FT-IR (KBr, υ/cm-1): 3449(O–
H), 3259 (N–H), 3055 (aromatic C–H), 2963-2870 (aliphatic C–
H), 1657 (C=O), 1617 (C=N), 1550 (C=C), 1484 (N=N), 1274
(C–O). 1H NMR (400 MHz, DMSO-d6) (ppm): syn/syn isomer,
39.5%: 11.76-11.74 (m, 4H, He or Hc), 8.50 (s, 2H, Hd), 8.17 (d, J
= 2.4 Hz, 2H, Hh), 7.89-7.71 (m, 6H, Hi, Hg), 7.43-7.34 (m, 4H,
Hk), 7.12-7.04 (m, 2H, Hf), 2.74-2.62 (m, 4H, Hl), 2.35-2.29 (m,
4H, Hb), 1.74-1.65 (m, 4H, Ha), 1.24 (t, J = 7.6 Hz, 6H, Hm);
syn/anti and/or anti/syn isomers, 48%: 11.76-11.74 (m, 2H, He or
Hc), 11.37 (s, 1H, He or Hc), 10.92 (br, 1H, He or Hc), 8.48 (s, 1H,
Hd (syn)), 8.36 (s, 1H, Hd (anti)), 8.26 (d, J = 2.4 Hz, 1H, Hh (anti)),
8.16 (d, J = 2.4 Hz, 1H, Hh (syn)), 7.89-7.71 (m, 6H, Hi, Hg), 7.43-
7.34 (m, 4H, Hk), 7.12-7.04 (m, 2H, Hf), 2.74-2.62 (m, 6H, Hl, Hb
(anti)), 2.35-2.29 (m, 2H, Hb (syn)), 1.74-1.65 (m, 4H, Ha), 1.24 (t, J
= 7.6 Hz, 3H, Hm (syn or anti)), 1.18 (t, J = 7.6 Hz, 3H, Hm (syn or anti));
anti/anti isomer, 12.5%: 11.37 (s, 2H, He or Hc), 10.92 (br, 2H, He
or Hc), 8.35 (s, 2H, Hd), 8.23 (d, J = 2.4 Hz, 2H, Hh), 7.89-7.71
(m, 6H, Hi, Hg), 7.43-7.34 (m, 4H, Hk), 7.12-7.04 (m, 2H, Hf),
2.74-2.62 (m, 8H, Hl, Hb), 1.74-1.65 (m, 4H, Ha), 1.24 (t, J = 7.6
Hz, 6H, Hm). 13C NMR (100 MHz, DMSO-d6, ppm): 174.46,
174.43, 169.02, 168.97, 160.32, 159.50, 150.76, 150.69, 147.61,
147.52, 145.65, 145.59, 145.21, 139.78, 139.70, 129.20, 129.16,
129.06, 126.11, 125.01, 124.80, 123.64, 122.85, 122.25, 122.01,
121.47, 121.40, 120.10, 117.65, 117.37, 34.39, 34.30, 32.40,
32.26, 28.52, 28.47, 25.28, 25.12, 24.58, 24.39, 15.82, 15.76.
Anal. Calcd. For C36H38N8O4 (%): C, 66.86; H, 5.92; N, 17.33.
Found: C, 66.95; H, 5.98; N, 17.29. HRMS-ESI (m/z) calcd. for
C36H39N8O4 [M + H]+ 647.3089, found 647.3093.
4.2.6. N'1 ,N'6 -bis((E)-5-((E)-(4-ethylphenyl)
diazenyl)-2-hydroxy-3-methoxybenzylidene)
adipohydrazide (1f)
Yield: 88%, mp 247-248 °C; FT-IR (KBr, υ/cm-1): 3416 (O–
H), 3198 (N–H), 3056 (aromatic C–H), 2961-2870 (aliphatic C–
H), 1670 (C=O), 1606 (C=N), 1547 (C=C), 1460 (N=N), 1267
(C–O). 1H NMR (400 MHz, DMSO-d6) (ppm): syn/syn isomer,
37.3%: 11.76 (s, 2H, Hc), 11.53 (br, 2H, He), 8.51 (s, 2H, Hd),
7.86-7.73 (m, 6H, Hh, Hi), 7.54 (d, J = 2.4 Hz, 2H, Hg), 7.44-7.34
(m, 4H, Hk), 3.96-3.91 (m, 6H, Hf), 2.75-2.63 (m, 4H, Hl), 2.36-
2.30 (m, 4H, Hb), 1.76-1.66 (m, 4H, Ha), 1.25 (t, J = 7.6 Hz, 6H,
Hm); syn/anti and/or anti/syn isomers, 48.5%: 11.76 (s, 1H, Hc (syn)
or He (syn)), 11.53 (br, 1H, Hc (syn) or He (syn)),11.38 (s, 1H, Hc (anti) or He
(anti)), 10.30 (br, 1H, Hc (anti) or He (anti)), 8.49 (s, 1H, Hd (syn)), 8.41 (s,
1H, Hd (anti)), 7.96 (d, J = 2.4 Hz, 1H, Hh (anti)), 7.86-7.73 (m, 5H,
Hh (syn), Hi), 7.52 (d, J = 2.4 Hz, 1H, Hg (syn)), 7.47 (d, J = 2.4 Hz,
1H, Hg (anti)), 7.44-7.34 (m, 4H, Hk), 3.96-3.91 (m, 6H, Hf), 2.75-
2.63 (m, 6H, Hl, Hb (anti)), 2.36-2.30 (m, 2H, Hb (syn)), 1.76-1.66 (m,
4H, Ha), 1.25 (t, J = 7.6 Hz, 3H, Hm), 1.20 (t, J = 7.6 Hz, 3H,
Hm); anti/anti isomer, 14.2%: 11.37 (s, 2H, Hc), 10.30 (br, 2H,
He), 8.40 (s, 2H, Hd), 7.93 (d, J = 2.4 Hz, 2H, Hh), 7.85-7.73 (m,
4H, Hi), 7.44-7.34 (m, 6H, Hg, Hk), 3.96-3.91 (m, 6H, Hf), 2.75-
2.63 (m, 8H, Hl, Hb), 1.76-1.66 (m, 4H, Ha), 1.25 (t, J = 7.6 Hz,
6H, Hm). 13C NMR (100 MHz, DMSO-d6, ppm): 174.48, 174.42,
168.98, 168.94, 150.71, 150.65, 150.45, 149.44, 149.24, 147.58,
147.52, 147.41, 145.37, 145.25, 145.15, 139.63, 129.22, 129.06,
122.87, 121.06, 119.50, 119.03, 117.65, 117.44, 104.51, 102.97,
102.76, 56.47, 56.41, 34.40, 34.30, 32.32, 32.18, 28.52, 25.22,
25.11, 24.52, 24.37, 15.81, 15.76. Anal. Calcd. For C38H42N8O6
(%): C, 64.57; H, 5.99; N, 15.85. Found: C, 64.51; H, 6.05; N,
15.97. HRMS-ESI (m/z) calcd. for C38H43N8O6 [M + H]+
707.3300, found 707.3304.
4.2.4. N'1 ,N'6 -bis((E)-2-hydroxy-5-((E)-(4-
nitrophenyl)diazenyl)benzylidene)adipohydrazide
(1d)
Yield: 77%, mp 306-307 °C; FT-IR (KBr, υ/cm-1): 3447 (O–
H), 3212 (N–H), 3053 (aromatic C–H), 2953 (aliphatic C–H),
1662 (C=O), 1613 (C=N), 1545 (C=C), 1517 (NO2 asymmetric),
1483 (N=N), 1341 (NO2 symmetric), 1284 (C–O). 1H NMR (400
MHz, DMSO-d6) (ppm): syn/syn isomer, 35.4%: 11.99 (s, 2H,
Hc or He), 11.79 (s, 2H, Hc or He), 8.56-8.20 (m, 8H, Hd, Hh, Hk),
8.10-7.70 (m, 6H, Hg, Hi), 7.18-7.10 (m, 2H, Hf), 2.36-2.30 (m,
4H, Hb), 1.77-1.68 (m, 4H, Ha); syn/anti and/or anti/syn isomers,
47.9%: 11.94 (s, 1H, Hc (syn) or He (syn)), 11.76 (s, 1H, Hc (syn) or He
(syn)), 11.40 (s, 1H, Hc (anti) or He (anti)), 11.24 (s, 1H, Hc (anti) or He (anti)),
8.56-8.20 (m, 8H, Hd, Hh, Hk), 8.10-7.70 (m, 6H, Hg, Hi), 7.18-
7.10 (m, 2H, Hf), 2.75-2.68 (m, 2H, Hb (anti)), 2.36-2.30 (m, 2H,
Hb (syn)), 1.77-1.68 (m, 4H, Ha); anti/anti isomer, 16.7%: 11.36 (s,
2H, Hc or He), 11.03 (s, 2H, Hc or He), 8.56-8.20 (m, 8H, Hd, Hh,
Hk), 8.10-7.70 (m, 6H, Hg, Hi), 7.18-7.10 (m, 2H, Hf), 2.75-2.68
(m, 4H, Hb), 1.77-1.68 (m, 4H, Ha). The product shows low
solubility in any appropriate solvents to allow for structural
characterization using 13C NMR. Anal. Calcd. For C32H28N10O8
(%): C, 56.47; H, 4.15; N, 20.58. Found: C, 56.55; H, 4.11; N,
20.51. HRMS-ESI (m/z) calcd. for C32H29N10O8 [M + H]+
681.2164, found 681.2161.
4.2.7. N'1 ,N'6 -bis((E)-5-((E)-(4-chlorophenyl)
diazenyl)-2-hydroxy-3-methoxybenzylidene)
adipohydrazide (1g)
Yield: 70%, mp 276-277 °C; FT-IR (KBr, υ/cm-1): 3441 (O–
H), 3187 (N–H), 3044 (aromatic C–H), 2958 and 2930 (aliphatic
C–H), 1657 (C=O), 1605 (C=N), 1539 (C=C), 1465 (N=N), 1268
4.2.5. N'1 ,N'6 -bis((E)-2-hydroxy-3-methoxy-5-((E)-
phenyldiazenyl)benzylidene) adipohydrazide (1e)
Yield: 84%, mp 277-278 °C; FT-IR (KBr, υ/cm-1): 3450 (O–
H), 3087 (aromatic C–H), 2991-2944 (aliphatic C–H), 1670
(C=O), 1581 (C=C), 1461(N=N), 1270 (C–O), 768, 691. 1H
NMR (400 MHz, DMSO-d6) (ppm): syn/syn isomer, 39.5%:
11.77 (s, 2H, Hc or He), 11.57 (br, 2H, He), 8.51 (s, 2H, Hd), 7.90-
7.79 (m, 6H, Hh, Hi), 7.62-7.50 (m, 8H, Hg, Hk, Hl), 3.96-3.91 (m,
1
(C–O), 751 (C-Cl). H NMR (400 MHz, DMSO-d6) (ppm):
syn/syn isomer, 34.6%: 11.72 (s, 2H, He), 11.33 (s, 2H, Hc), 8.48
(s, 2H, Hd), 7.87-7.74 (m, 6H, Hh, Hi), 7.62-7.35 (m, 6H, Hg, Hk),
3.90-3.86 (m, 6 H, Hf), 2.31-2.30 (m, 4H, Hb), 1.72-1.66 (m, 4H,
Ha); syn/anti and/or anti/syn isomers, 47.7%: 11.72 (s, 2H, He or
Hc), 11.33 (s, 2H, He or Hc), 8.45 (s, 1H, Hd (syn)), 8.39 (s, 1H, Hd
(anti)), 7.95 (d, J = 7.2 Hz, 1H, Hh (anti)), 7.87-7.74 (m, 5H, Hh (syn)
,